FAQ

FAQ published on January 20, 2020
Dr. Komrokji discusses how fedratinib fits as a treatment option for myelofibrosis.
FAQ published on January 20, 2020
Dr. Komrokji discusses the importance of obtaining blood counts before initiating therapy with ruxolitinib and subsequently every two to four weeks thereafter.
FAQ published on January 20, 2020
Dr. Komrokji discusses the importance of testing thiamine levels before administering fedratinib.
Page 2 of 2
Results 11 - 13 of 13